Prevalence of cerebral visual impairment in developmental and Epileptic Encephalopathies: a systematic review protocol.
Cerebral visual impairment
Cortical visual impairment
Developmental and Epileptic Encephalopathy
Epilepsy
Pediatrics
Prevalence
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
31 Aug 2024
31 Aug 2024
Historique:
received:
09
04
2024
accepted:
19
08
2024
medline:
1
9
2024
pubmed:
1
9
2024
entrez:
31
8
2024
Statut:
epublish
Résumé
Developmental and Epileptic Encephalopathies (DEEs) are defined by drug-resistant seizures and neurodevelopmental disorders. Over 50% of patients have a genetic cause. Studies have shown that patients with DEEs, regardless of genetic diagnosis, experience a central visual function disorder known as Cerebral (cortical) Visual Impairment (CVI). The prevalence of CVI in DEE patients is currently unknown. A quantitative synthesis of existing data on the prevalence rates of this condition would aid in understanding the magnitude of the problem, outlining future research, and suggesting the need for therapeutic strategies for early identification and prevention of the disorder. The protocol followed the PRISMA-P statement for systematic review and meta-analysis protocols. The review will adhere to the JBI Manual for Evidence Synthesis (Systematic Reviews of Prevalence and Incidence) and use the CoCoPop framework to establish eligibility criteria. We will conduct a comprehensive search of several databases, including MEDLINE, EMBASE, Science Direct, Scopus, PsychINFO, Wiley, Highwire Press, and Cochrane Library of Systematic Reviews. Our primary focus will be determining the prevalence of cerebral visual impairments (Condition) in patients with developmental and epileptic encephalopathy (Population). To ensure clarity, we will provide a narrative summary of the risk of bias in the studies we include. The Cochrane Q statistic will be used to assess heterogeneity between studies. If the quantitative synthesis includes more than 10 studies, potential sources of heterogeneity will be investigated through subgroup and meta-regression analyses. Meta(bias)es analysis will also be performed. The quality of evidence for all outcomes will be evaluated using the Grading of Recommendations Assessment Development and Evaluation (GRADE) working group methodology. This protocol outlines a systematic review and meta-analysis to identify, collect, evaluate, and integrate epidemiological knowledge related to the prevalence of CVI in patients with DEEs. To the best of our knowledge, no other systematic review and meta-analysis has addressed this specific issue. The results will provide useful information for understanding the extent of the problem, outlining future research, and suggesting the need for early identification strategies. This Systematic Review Protocol was registered in PROSPERO (CRD42023448910).
Sections du résumé
BACKGROUND
BACKGROUND
Developmental and Epileptic Encephalopathies (DEEs) are defined by drug-resistant seizures and neurodevelopmental disorders. Over 50% of patients have a genetic cause. Studies have shown that patients with DEEs, regardless of genetic diagnosis, experience a central visual function disorder known as Cerebral (cortical) Visual Impairment (CVI). The prevalence of CVI in DEE patients is currently unknown. A quantitative synthesis of existing data on the prevalence rates of this condition would aid in understanding the magnitude of the problem, outlining future research, and suggesting the need for therapeutic strategies for early identification and prevention of the disorder.
METHODS
METHODS
The protocol followed the PRISMA-P statement for systematic review and meta-analysis protocols. The review will adhere to the JBI Manual for Evidence Synthesis (Systematic Reviews of Prevalence and Incidence) and use the CoCoPop framework to establish eligibility criteria. We will conduct a comprehensive search of several databases, including MEDLINE, EMBASE, Science Direct, Scopus, PsychINFO, Wiley, Highwire Press, and Cochrane Library of Systematic Reviews. Our primary focus will be determining the prevalence of cerebral visual impairments (Condition) in patients with developmental and epileptic encephalopathy (Population). To ensure clarity, we will provide a narrative summary of the risk of bias in the studies we include. The Cochrane Q statistic will be used to assess heterogeneity between studies. If the quantitative synthesis includes more than 10 studies, potential sources of heterogeneity will be investigated through subgroup and meta-regression analyses. Meta(bias)es analysis will also be performed. The quality of evidence for all outcomes will be evaluated using the Grading of Recommendations Assessment Development and Evaluation (GRADE) working group methodology.
DISCUSSION
CONCLUSIONS
This protocol outlines a systematic review and meta-analysis to identify, collect, evaluate, and integrate epidemiological knowledge related to the prevalence of CVI in patients with DEEs. To the best of our knowledge, no other systematic review and meta-analysis has addressed this specific issue. The results will provide useful information for understanding the extent of the problem, outlining future research, and suggesting the need for early identification strategies.
SYSTEMATIC REVIEW REGISTRATIONS
BACKGROUND
This Systematic Review Protocol was registered in PROSPERO (CRD42023448910).
Identifiants
pubmed: 39217383
doi: 10.1186/s13643-024-02638-6
pii: 10.1186/s13643-024-02638-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
223Informations de copyright
© 2024. The Author(s).
Références
Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2020;63(6):1349–97.
doi: 10.1111/epi.17239
Malkowicz DE, Myers G, Leisman G. Rehabilitation of cortical visual impairment in children. Int J Neurosci. 2006Sep;116(9):1015–33.
doi: 10.1080/00207450600553505
pubmed: 16861165
Fazzi E, Signorini SG, Bova SM, et al. Spectrum of visual disorders in children with cerebral visual impairment. J Child Neurol. 2007;22(3):294–301.
doi: 10.1177/08830738070220030801
pubmed: 17621499
Demarest S, Olson HE, Moss A, et al. CDKL5 Deficiency Disorder: Relationship between genotype, epilepsy, cortical visual impairment and development. Epilepsia. 2019Aug;60(8):1733–42.
doi: 10.1111/epi.16285
pubmed: 31313283
pmcid: 7098045
Brock D, Fidell A, Thomas J, et al. Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement. J Child Nurol. 2021;36(11):974–80.
doi: 10.1177/08830738211019284
Olson HE, Costantini JA, Swanson LC, et al. Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure. Dev Med Child Neurol. 2021;63(11):1308–15.
doi: 10.1111/dmcn.14908
pubmed: 34028805
pmcid: 8782241
Quintiliani M, Ricci D, Petrianni M, et al. Cortical Visual Impairment in CDKL5 Deficiency Disorder. Front Neurol. 2022;12:1–8.
doi: 10.3389/fneur.2021.805745
Saby JN, Mulcahey PJ, Zavez AE, et al. Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder. Brain. 2022;4:1–15
Olson HE, Demarest ST, Pestana-Knight EM, et al. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review. Ped Neurol. 2019;97:18–25.
doi: 10.1016/j.pediatrneurol.2019.02.015
Guzzetta F, Frisone MF, Ricci D, et al. Development of Visual Attention in West Syndrome. Epilepsia. 2002;43(7):757–63.
doi: 10.1046/j.1528-1157.2002.34601.x
pubmed: 12102680
Randò T, Bancale A, Baranello G, et al. Visual Function in Infants with West Syndrome: Correlation with EEG patterns. Epilepsia. 2004;45(7):781–6.
doi: 10.1111/j.0013-9580.2004.41403.x
pubmed: 15230702
Guzzetta F, Cioni G, Mercuri E, et al. Neurodevelopmental evolution of West Syndrome: A 2-year prospective study. Eu J Ped Neurol. 2008;12:387–97.
doi: 10.1016/j.ejpn.2007.10.008
Chieffo D, Ricci D, Baranello G, et al. Early development in Dravet syndrome; visual function impairment precedes cognitive decline. Epilepsy Res. 2011;93:73–9.
doi: 10.1016/j.eplepsyres.2010.10.015
pubmed: 21109403
Ricci D, Chieffo D, Battaglia D, et al. A prospective longitudinal study on visuo-cognitive development in Dravet syndrome: Is there a “dorsal stream vulnerability”? Epilepsy Res. 2015;109:57–64.
doi: 10.1016/j.eplepsyres.2014.10.009
pubmed: 25524843
Berg AT, Mahida S, Poduri A, et al. KCNQ2-DEE: developmental or epileptic encephalopathy? ANNALS of Clinical and Translational Neurology. 2021;8(3):666–76.
doi: 10.1002/acn3.51316
pubmed: 33616268
pmcid: 7951099
Helbig KL, Goldberg EM, et al. SCN3A-Related Neurodevelopmental Disorder. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews. Seattle (WA): University of Washington; 2021. p. 1993–2022.
Gardella E, Marini C, Trivisano M, et al. The phenotype of SCN8A developmental and epileptic encephalopathy. Neurology. 2018;91:e1112–24.
doi: 10.1212/WNL.0000000000006199
pubmed: 30171078
Platzer K, Yuan H, Schütz H, et al. GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects. J Med Genet. 2017;54(7):460–70.
doi: 10.1136/jmedgenet-2016-104509
pubmed: 28377535
Inguaggiato E, Sgandurra G, Cioni G. Brain plasticity and early development: Implications for early intervention in neurodevelopmental disorders. Neuropsychiatrie de l’Enfance et de l’Adolescence. 2017;65(5):299–306.
doi: 10.1016/j.neurenf.2017.03.009
Spolidoro M, Sale A, Berardi N, Maffei L. Plasticity in the adult brain: lessons from the visual system. Exp Brain Res. 2009Jan;192(3):335–41.
doi: 10.1007/s00221-008-1509-3
pubmed: 18668231
Caleo M, Tropea D, Rossi C, et al. Environmental enrichment promotes fiber sprouting after deafferentation of the superior colliculus in the adult rat brain. Exp Neurol. 2009;216(2):515–9.
doi: 10.1016/j.expneurol.2008.12.016
pubmed: 19168061
Sale A, Berardi N, Maffei L. Enrich the environment to empower the brain. Trends Neurosci. 2009Apr;32(4):233–9.
doi: 10.1016/j.tins.2008.12.004
pubmed: 19268375
Guzzetta A, Baldini S, Bancale A, et al. Massage accelerates brain development and the maturation of visual function. J Neurosci. 2009;29(18):6042–5.
doi: 10.1523/JNEUROSCI.5548-08.2009
pubmed: 19420271
pmcid: 6665233
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
doi: 10.1186/2046-4053-4-1
pubmed: 25554246
pmcid: 4320440
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
doi: 10.1001/jama.283.15.2008
pubmed: 10789670
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.
doi: 10.1097/XEB.0000000000000054
pubmed: 26317388
Migliavaca CB, Stein C, Colpani V, et al. Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Syn Meth. 2022;13(3):363–7.
doi: 10.1002/jrsm.1547
von Hippel PT. The heterogeneity statistic I2 can be biased in small meta-analyses. BMC Med Res Methodol. 2015;15:35.
doi: 10.1186/s12874-015-0024-z
Higgins JPT, Li T. Exploring Heterogeneity. In: Egger M, Higgins JPT, Davey Smith G, editors. In Systematic Reviews in Health Research. 2022.
Miles J. R Squared, Adjusted R Squared. In: Balakrishnan N, Colton T, Everitt B, Piegorsch W, Ruggeri F, Teugels JL, editors. In Wiley StatsRef: Statistics Reference Online. 2014.
Ding D, Gandy A, Hahn G. A simple method for implementing Monte Carlo tests. Comput Stat. 2020;35:1373–92.
doi: 10.1007/s00180-019-00927-6
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
doi: 10.1136/bmj.315.7109.629
pubmed: 9310563
pmcid: 2127453
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6.
doi: 10.1136/bmj.39489.470347.AD
pubmed: 18436948
Borges Migliavaca C, Stein C, Colpani V, et al. How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol. 2020;20:96.
doi: 10.1186/s12874-020-00975-3
pubmed: 32336279
pmcid: 7184711
Guyatt GH, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94.
doi: 10.1016/j.jclinepi.2010.04.026
pubmed: 21195583
Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.
doi: 10.1016/j.jclinepi.2010.09.012
pubmed: 21194891